Leaderboards/cns lymphoma diagnosis and treatment

cns lymphoma diagnosis and treatment

Last updated June 2, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Andrés J.M. Ferreri
Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele
99
2
M. Dreyling
Ludwig-Maximilians-Universität München
90
3
David Reinecke
University of Cologne
80
4
Daniel A. Orringer
New York University
70
5
Junhan Zhao
Harvard University
60
6
Kun‐Hsing Yu
Brigham and Women's Hospital
50
7
Georgios Mangioris
Mayo Clinic in Arizona
40
8
Αναστασία Ζεκερίδου
Jacksonville College
30
9
Saskia Räuber
University of Münster
20

Rising Stars Papers

Insufficient data

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Andrés J.M. Ferreri
Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele
99
2
Mihir Gupta
University of California San Diego
90
3
Alice A. Lee
Children's Hospital at Montefiore
80
4
Trine Trab
Unknown
70
5
Jennifer L. Crombie
Dana-Farber Cancer Institute
60
6
Toby A. Eyre
Oxford University Hospitals NHS Trust
50
7
Martine E.D. Chamuleau
Hovon
40
8
Trusha Shah
University of Washington
30
9
Lia Gore
University of Colorado Cancer Center
20
10
Renata Walewska
Dorset HealthCare University NHS Foundation Trust
10

Emerging Leaders Papers

Insufficient data

All-Time Leaders

The canon

All-Time Leaders Researchers

1
Solange Peters
University Hospital of Lausanne
99
2
Marco Ladetto
Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo
90
3
Joachim Yahalom
Unknown
80
4
Rafael Peris‐Bonet
Universitat de València
70
5
Catherine Patte
Institut Gustave Roussy
60
6
Bruce W. Dana
Unknown
50
7
Enriqueta Felip
University Hospital of Lausanne
40
8
Martin Reck
German Center for Lung Research
30
9
Jørn Herrstedt
Odense University Hospital
20
10
S B Murphy
Comer Children's Hospital
10

All-Time Leaders Papers

1
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
Annals of Oncology|2018
2.9k cit.
2
Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Annals of Oncology|2015
920 cit.
3
Preoperative Chemotherapy Plus Surgery Versus Surgery Plus Adjuvant Chemotherapy Versus Surgery Alone in Early-Stage Non–Small-Cell Lung Cancer
Journal of Clinical Oncology|2010
426 cit.
4
Non-small-cell lung cancer
Nature Reviews Disease Primers|2024
407 cit.
5
Rapamycin-Sensitive Pathway Regulates Mitochondrial Membrane Potential, Autophagy, and Survival in Irradiated MCF-7 Cells
Cancer Research|2005
216 cit.
6
Guide to detecting epidermal growth factor receptor (<i>EGFR</i>) mutations in ctDNA of patients with advanced non-small-cell lung cancer
Oncotarget|2016
142 cit.
7
Overview of Checkpoint Inhibitors Mechanism of Action: Role of Immune-Related Adverse Events and Their Treatment on Progression of Underlying Cancer
Frontiers in Medicine|2022
84 cit.
8
Fluorescence In Situ Hybridization and Immunohistochemistry as Diagnostic Methods for ALK Positive Non-Small Cell Lung Cancer Patients
PLoS ONE|2013
70 cit.

Reagents for cns lymphoma diagnosis and treatment

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Recommended

Best all-around

Cell Signaling Technology

RIPA Buffer (10X)

#9806$93
View Evidence →Cell Signaling Technology

Phospho-KAP-1 (Ser824) Antibody

#4127$153
View Evidence →Cell Signaling Technology

STIM1 Antibody

#4916$317
View Evidence →

🌟 All-Time

Most validated

Agilent/Dako

Mutated melanoma-associated antigen 1

Cited in 8 papers
#M7259
View Evidence →Innovative Research

Mouse Anti-Human CD1a Monoclonal Antibody, Alexa Fluor 488 Conjugated, Clone 143

#CD1A20
View Evidence →Cell Signaling Technology

OX40L (D6K7R) Rabbit Monoclonal Antibody (BSA and Azide Free)

#51635$865
View Evidence →